Get started
Author

Antonella Didio

Observed name: Didio, Antonella
ORCID: 0000-0001-9041-9400
Observed ORCID: 0000-0001-9041-9400
OpenAlex ID: A5069569487
Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 2018
2022 · Janet Sultana, Salvatore Crisafulli, et al. · Pharmacoepidemiology and Drug Safety · 21
PDF
An overview of the efficacy and safety of deferiprone in paediatric patients with congenital haemoglobinopathies and chronic iron overload
2019 · Adriana Ceci, Rosa Conte, et al. · Expert Opinion on Orphan Drugs · 8
Ethical and regulatory requirements for conducting researcher-driven large-scale multinational genetic haematological studies: the INHERENT experience
2025 · Antonella Didio, Viviana Giannuzzi, et al. · Health Research Policy and Systems · 4
PDF
Understanding the Needs of Healthcare Professionals Involved in Sickle Cell Disease Management in Nigeria: A Grounded Theory Study
2026 · Abubakar Abdulkareem, Lucia Ruggieri, et al. · InfoScience Trends · 2
PDF
Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed
2023 · Adriana Ceci, Rosa Conte, et al. · Frontiers in Medicine · 2
PDF
Descriptive Analysis of Pediatric Studies Included in the European Union Post-Authorization Study Register from 2010 to 2023
2025 · Annalisa Landi, Giorgio Reggiardo, et al. · Pediatric Reports · 1
PDF
Special Issue “Personalized Medicine in Blood Disease of Children”
2024 · Adriana Ceci, Petros Kountouris, et al. · Journal of Personalized Medicine · 1
PDF
Works count: 11
Citation count: 39
H-index: 3
I10-index: 1
Year
Topic
Type